Enel 9-Month Profit Down

Enel (ENLAY.PK,EN) Thursday said its profit attributable to owners of the parent for first nine months of 2021 dropped to 1.76 billion euros from 2.51 billion euros last year.

Earnings, on a per share basis, were $0.17, down from $0.24 last year.

Ordinary EBITDA for the nine-month period was 12.67 billion euros, compared to 12.77 billion euros last year.

Revenues for the first nine months of 2021 rose to 108.2 billion euros from 58.8 billion euros last year.

The 84% surge in revenues is attributable to all business segments, mainly reflecting an increase in the quantities of electricity and gas sold at rising average prices and an increase in the quantity of electricity generated.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
IBSA Pharma Inc. is recalling 27 lots of TIROSINT-SOL (levothyroxine sodium) Oral Solution to the consumer level due to subpotency, the U.S. Food and Drug Administration said. TIROSINT-SOL is indicated for Hypothyroidism and Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression. Meanwhile, the recall does not apply to TIROSINT (levothyroxine sodium) capsules. The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months. It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received FDA approval. German banking major Deutsche Bank AG reported Thursday a significantly higher profit in its fourth quarter and fiscal 2022, mainly reflecting a tax benefit in the U.S, despite weakness in Investment Bank and asset management revenues. The company said it recorded its highest annual profit, both before and after tax, since 2007. However, Deutsche Bank shares were losing around 4 percent...
Follow RTT